|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 315.60 CHF | -0.35% |
|
-0.41% | -3.84% |
| 04-10 | Health Care Down on Retreat from Biotech -- Health Care Roundup | DJ |
| 04-10 | ROCHE HOLDINGS AG : UBS reiterates its Buy rating | ZD |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals - Roche Pharmaceuticals | 45.71B | 46.35B | 44.43B | 46.34B | 48.07B | |||||
Total Assets | 44.86B | 43.04B | 46.08B | 45.52B | 48.3B | |||||
CAPEX | -2.79B | -2.3B | -3.12B | -1.31B | -1.21B | |||||
D&A | 2.66B | 2.14B | 1.82B | 1.72B | 1.64B | |||||
Operating Income | 12.6B | 11.32B | 13.87B | 18.69B | 20.3B | |||||
Pharmaceuticals - Chugai | 8.36B | 9.27B | 7.2B | 6.88B | 7.02B | |||||
Total Assets | 7.89B | 8.89B | 6.59B | 6.38B | 6.66B | |||||
CAPEX | -727M | -532M | -490M | -307M | -352M | |||||
D&A | 249M | 221M | 196M | 177M | 175M | |||||
Operating Income | 3.52B | 3.99B | 2.92B | 3.28B | 3.35B | |||||
EBITDA | 19.89B | 20.7B | 21.43B | 23.36B | 24.8B | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Diagnostics | 17.86B | 17.82B | 14.16B | 14.46B | 13.96B | |||||
Total Assets | 21.46B | 21.59B | 20.48B | 22.55B | 21.63B | |||||
CAPEX | -1.78B | -1.76B | -1.98B | -1.81B | -2.01B | |||||
EBITDA | 5.31B | 4.8B | 3.88B | 3.7B | 3.34B | |||||
D&A | 1.46B | 1.42B | 1.37B | 1.45B | 1.5B | |||||
Operating Income | 3.32B | 3.32B | 2.17B | 2.4B | 2B | |||||
Elimination | -6.08B | -7.02B | -5.35B | -5.29B | -5.7B | |||||
Total Assets | -4.08B | -4.63B | -3.03B | -2.98B | -3.74B | |||||
Operating Income | -596M | -497M | 349M | 38M | -202M | |||||
Total Assets | - | - | - | - | - | |||||
Total Assets | 6.85B | 4.99B | 5.38B | 6.98B | 5.58B | |||||
Total Assets | 6.18B | 4.78B | 5.13B | 10.34B | 9.89B | |||||
Operating Income | -694M | -662M | -3.91B | -3.59B | -3.6B | |||||
D&A | 70M | 69M | 77M | 72M | 67M | |||||
EBITDA | -506M | -486M | -3.34B | -3.52B | -3.53B | |||||
CAPEX | -103M | -92M | -88M | -69M | -45M | |||||
Total Assets | 420M | 445M | 555M | 631M | 668M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 28.06B | 29.31B | 28.35B | 30.17B | 30.72B | |||||
Total Assets | 25.54B | 23.56B | 26.41B | 27.33B | 27.58B | |||||
CAPEX | -925M | -881M | -1.28B | -1.1B | -992M | |||||
Rest of Europe | 11.38B | 10.33B | 9.7B | 10.29B | 10.86B | |||||
Total Assets | 2.07B | 1.85B | 1.67B | 2.01B | 2.08B | |||||
CAPEX | -344M | -278M | -309M | -319M | -458M | |||||
China | - | - | - | - | 4.82B | |||||
Total Assets | - | - | - | - | 730M | |||||
CAPEX | - | - | - | - | -129M | |||||
Rest of Asia | 9.76B | 9.85B | 8.89B | 9.08B | 3.78B | |||||
Total Assets | 1.66B | 1.53B | 1.41B | 1.48B | 725M | |||||
CAPEX | -293M | -299M | -323M | -312M | -283M | |||||
Latin America | 2.75B | 2.87B | 2.97B | 3.25B | 3.24B | |||||
Total Assets | 333M | 368M | 418M | 457M | 462M | |||||
CAPEX | -116M | -138M | -192M | -176M | -149M | |||||
Germany | 4.32B | 3.32B | 2.89B | 2.94B | 3.12B | |||||
Total Assets | 5.36B | 5.32B | 5.26B | 5.49B | 5.61B | |||||
CAPEX | -635M | -668M | -612M | -612M | -666M | |||||
Japan | 5.07B | 6.45B | 4.46B | 3.29B | 3.12B | |||||
Total Assets | 3.06B | 2.93B | 2.7B | 2.72B | 2.68B | |||||
CAPEX | -609M | -456M | -448M | -315M | -364M | |||||
Africa, Australia and Oceania | 1.48B | 1.52B | 1.21B | 1.25B | 1.36B | |||||
Total Assets | 145M | 138M | 131M | 151M | 149M | |||||
CAPEX | -45M | -40M | -44M | -56M | -42M | |||||
Switzerland | 2.12B | 1.67B | 1.12B | 1.23B | 1.34B | |||||
Total Assets | 9.11B | 8.98B | 9.12B | 9.08B | 9.54B | |||||
CAPEX | -857M | -639M | -561M | -600M | -524M | |||||
Rest of North America | 916M | 1.1B | 838M | 889M | 982M | |||||
Total Assets | 58M | 51M | 41M | 198M | 190M | |||||
CAPEX | -2M | -3M | -5M | -6M | -12M |
- Stock Market
- Equities
- ROP Stock
- ROG Stock
- Financials Roche Holding AG
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















